target_id,symbol,name,uniprot,indication,modality,mechanism
HDAC6,HDAC6,Benchmark: selective HDAC6 inhibitors,,Neurodegenerative diseases / cancer,Benchmark dataset,HDAC6 inhibitors: ricolinostat IC50 variable by cell line, citarinostat IC50 2.6nM (HDAC6); induces Î±-tubulin acetylation; synergistic with paclitaxel in breast cancer
